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Purpose: To report the clinical and cytogenetic characteristics of choroidal melanoma in Vietnamese Asians.
Methods: In three Vietnamese Asians with choroidal melanoma, transscleral fine needle aspiration biopsy (FNAB) was
performed immediately before Iodine-125 brachytherapy. Biopsy was examined for cytopathology, fluorescence in situ
hybridization (FISH) for the centromere of chromosome 3, and analyzed by 250K whole genome Mapping Array and
U133 plus 2.0 Expression Array.
Results: Three Vietnamese Asian men (50, 59, and 30 years of age) with clinical diagnosis of choroidal melanoma and
no evidence of metastasis had FNAB immediately before Iodine-125 brachytherapy. Cytopathology showed heavily
pigmented cells suggestive of or consistent with melanoma. Mapping Array and Expression Array revealed cytogenetic
aberrations and gene expression profiles characteristic of choroidal melanoma. One patient (Case 2) with chromosome 3
loss and chromosome 8q gain developed biopsy-proven liver metastasis three years after brachytherapy. One patient (Case
1) with chromosome 6p, 9q and 17q gain and a second patient (Case 3) with 6p, 8q and 9q gains and losses in 6q and 8p
have had no evidence of metastasis three years after brachytherapy.
Conclusions: In this series of Vietnamese Asians with heavily pigmented choroidal melanoma, the clinical characteristics,
cytogenetic aberrations and gene expression profiles were similar to characteristics in other ethnic/racial groups and the
cytogenetic aberration of chromosome 3 loss was associated with the development of liver metastasis.
Choroidal  melanoma  is  the  most  common  primary
intraocular  malignancy  in  adults.  Studies  from  various
countries have reported annual incidence rates between 5.3
and 10.9 cases per million [1]. A recent report found that the
annual incidence of choroidal melanoma in the United States
per  million  was  6.02  in  non-Hispanic  whites,  1.67  in
Hispanics, 0.38 in Asians, 0 in Native Americans, and 0.31 in
blacks [2].
Asian refers to persons with origin in any of the original
peoples of Asia and is further characterized by culture and
ancestry to a specific country or region [3]. In this context,
choroidal melanoma has been reported in Japanese Asians,
Chinese  Asians,  Thai  Asians,  and  others  of  Asian  origin
[4-7].  We  are  not  aware,  however,  of  a  prior  report  of
choroidal melanoma in Vietnamese Asians.
We  report  a  series  of  three  Vietnamese  Asians  with
choroidal melanoma. The clinical presentation and clinical
course of disease, the cytogenetic aberrations and the gene
expression profiles revealed by high-density single nucleotide
polymorphism (SNP) mapping array and expression array are
presented.
METHODS
All  studies  were  performed  in  accordance  with  the
Declaration  of  Helsinki  and  the  United  States  Health
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Insurance  Portability  and  Accountability  Act  (HIPAA)  of
1996. All participants gave informed consent and all studies
were approved by the Office of Human Research Protection
(Institutional Review Board) of the University of California,
Los Angeles.
Patients were self-declared Vietnamese Asians on the
basis of Vietnamese ancestry and identification with the social
and cultural characteristics of Vietnam [3].
Clinical  diagnosis  of  choroidal  melanoma  was
established by comprehensive ophthalmology examination,
fundus  photography,  fluorescein  angiography,  and
ultrasonography.
Transscleral  fine  needle  aspiration  biopsy  (FNAB),
cytopathology, fluorescence in situ hybridization (FISH) for
the  centromere  of  chromosome  3,  and  analysis  by  250K
Mapping  Array  (Affymetrix,  Santa  Clara,  CA)  for
chromosome  copy  number  and  U133  plus  2.0  Array
(Affymetrix)  for  gene  expression  were  performed  as
described  previously  [8-11].  Briefly,  probe  preparation,
hybridization,  and  reading  were  performed  by  the  UCLA
DNA Microarray Core (Los Angeles, CA), according to the
standard  96-well  protocol  published  by  Affymetrix.  Copy
number variation was computed using CNAT v4.0.1 software
from Affymetrix.
RESULTS
Case 1: A previously healthy 50-year-old Vietnamese man
presented with a three month history of photopsia and “black
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231vision” in the left eye. Visual acuity was 20/20 in the right eye
and Count Fingers at 3 feet in the left eye. The left eye had an
inferior and central field defect and left exotropia was present.
The right eye was unremarkable. Funduscopy of the left eye
revealed  a  heavily  pigmented  choroidal  tumor  in  the
superonasal periphery with extensive subretinal hemorrhage
in the superior fundus and upper part of the macula (Figure
1). Ultrasonography showed a mushroom-shaped choroidal
tumor with low to medium reflectivity, height of 8.10 mm and
basal dimensions of 9.99 mm by 11.20 mm.
With clinical diagnosis of choroidal melanoma, left eye,
and no evidence of metastasis, the patient was treated with
Iodine-125  brachytherapy  and  transscleral  fine  needle
aspiration  biopsy  (FNAB)  immediately  before  plaque
placement.  Cytopathology  showed  pigmented  cells
suspicious  for  melanoma  and  fluorescence  in  situ
hybridization  (FISH)  for  chromosome  3  revealed  normal
disomy pattern. Whole genome Mapping Array demonstrated
chromosome gains in 6p, 9q and 17q (Figure 2).
The patient has been followed for three and a half years
after brachytherapy with liver function testing and imaging by
positron emission tomography-computed tomography (PET-
CT)  yearly.  There  has  been  no  evidence  of  melanoma
metastasis.
Case 2: A previously healthy 59-year-old Vietnamese man
presented with sudden onset of decreased vision in the left eye.
Best corrected visual acuity was 20/20 in the right eye and
Hand Motions at 2 feet in the left eye. The right eye was
Figure 1. Color fundus photograph of
the  left  eye  in  Case  1  at  initial
presentation demonstrates a superonasal
pigmented choroidal melanoma.
Figure 2. Chromosomal aberrations determined by high-density genome single nucleotide polymorphism mapping (SNP) array in fine needle
aspiration biopsy specimens. Summary of accumulated chromosomal gain and loss data from GeneChip 250k NspI mapping arrays for biopsies
of the three patients is demonstrated. Red boxes denote whole or partial loss; green boxes denote a whole or partial gain; green boxes labeled
2× denote a two-copy gain.
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232unremarkable. Funduscopy of the left eye revealed a dense
vitreous  hemorrhage  that  obscured  details  of  a  choroidal
tumor  in  the  superotemporal  equatorial  region.
Ultrasonography showed a dome-shaped choroidal mass with
medium to high reflectivity, height of 6.29 mm and basal
measurements of 9.36 mm by 11.77 mm.
Following clinical diagnosis of choroidal melanoma, left
eye, and systemic medical evaluation that showed no evidence
of  metastasis,  the  patient  was  treated  with  Iodine-125
brachytherapy. FNAB immediately before plaque application
showed densely pigmented cells suspicious for melanoma and
consistent  with  necrotizing  melanocytoma.  FISH  for
chromosome 3 revealed normal disomy pattern, but Mapping
Array documented chromosome 3 loss and 8q gain (Figure 2).
One year after brachytherapy, the vitreous hemorrhage
had cleared and funduscopy revealed a melanotic choroidal
tumor that measured 5.57 mm in height by ultrasonography
(Figure 3). Liver function testing and PET-CT imaging was
performed yearly. Three years after brachytherapy, imaging
studies demonstrated liver lesions that were biopsy-proven to
be melanoma metastases.
Case 3: A 30-year-old Vietnamese man with a history of laser-
assisted in situ keratomileusis (LASIK) two years previously
was  referred  because  of  pigmented  lesion  in  the  left  eye
detected on LASIK follow-up examination. Visual acuity was
20/20  in  each  eye.  The  right  eye  had  no  significant
abnormality. Funduscopy of the left eye showed a pigmented
choroidal tumor in the inferotemporal equatorial region with
overlying subretinal fluid (Figure 4). Fluorescein angiography
demonstrated intratumor vascularization and ultrasonography
revealed a dome-shaped tumor with low internal reflectivity,
height of 3.92 mm and basal measurements of 10.70 mm by
11.07 mm.
Choroidal  melanoma  was  diagnosed  and  systemic
medical evaluation showed no evidence of metastasis. The left
eye  was  treated  with  Iodine-125  brachytherapy.  FNAB
immediately  before  plaque  placement  showed  pigmented
cells  diagnostic  of  choroidal  melanoma  and  FISH  for
chromosome 3 had normal disomy pattern. Mapping Array
demonstrated chromosomal aberrations consisting of gains in
6p, 8q and 9q as well as losses in 6q and 8p.
The patient has been followed for three and a half years
after brachytherapy with liver function testing and imaging by
PET-CT yearly. There has been no evidence of melanoma
metastasis.
Molecular  analysis:  The  results  of  high  density,  whole
genome 250K Mapping Array for the three cases are presented
in Figure 2. Loss of one copy of chromosome 3 (monosomy
Figure 3. Color fundus photograph of
the left eye in Case 2, one year after
Iodine-125  plaque  brachytherapy,
demonstrates  a  regressed  pigmented
choroidal melanoma.
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2333) was demonstrated in one patient (Case 2). FISH in this
patient showed normal disomy signal pattern, but the patient
progressed to biopsy proven liver metastasis three years after
brachytherapy.
The  two  other  patients  (Case  1  and  Case  3)  had
chromosome 6p gain in the absence of chromosome 3 loss, as
well as 9q and 17q gain in Case 1 and gains in 8q and 9q and
losses in 6q and 8p in Case 3. These patients have been
followed for three years after brachytherapy without evidence
of melanoma metastasis.
The results of U133 plus 2.0 Array for gene expression
for Case 2 and 3 with respect to the 25 most highly upregulated
genes  and  20  most  down-regulated  genes  identified  in  a
previous study of monosomy 3 choroidal melanomas relative
to chromosome 6p [11] choroidal melanomas are shown in
Figure  5.  Insufficient  RNA  was  available  to  perform  this
analysis in Case 1.
DISCUSSION
In this series of three Vietnamese men, clinical presentation
of  choroidal  melanoma  with  photopsia,  vision  loss  or
discovery on ophthalmologic examination, and appearance of
a  dome-shaped  or  mushroom-shaped  choroidal  mass  with
subretinal fluid or hemorrhage, and low to medium reflectivity
on  ultrasonography  was  comparable  to  presentation  of
choroidal melanoma in other ethnic and racial groups. Even
the heavy pigmentation in the tumor of Vietnamese men was
equivalent to the heavy pigmentation of choroidal melanoma
pigmentation  reported  in  Asians  from  Japan,  China,  and
Thailand [4-6].
Of particular significance in this report of Vietnamese
adults were the melanoma cytogenetic abnormalities and gene
expression profiles. Cytogenetic aberrations in the choroidal
melanomas included chromosome 3 loss by Mapping Array
in Case 2 and chromosome 6p gain with normal chromosome
3 disomy in Case 1 and Case 3. Surprisingly, FISH for the
centromere of chromosome 3 in Case 2 showed a normal
pattern of disomy. This may represent tumor heterogeneity or
cells from normal stroma or adjacent normal tissue in the
sample studied by FISH. Whole gene Mapping Array, which
is a more reliable test9, documented chromosome 3 loss in
Case 2.
Gene expression in choroidal melanoma of these three
Vietnamese men showed profiles of upregulation and down-
regulation for the 25 most upregulated and the 20 most down-
regulated genes in a comparative gene list. The comparative
gene list was derived from a comparison of gene expression
in  59  choroidal  melanomas  comparing  melanomas  with
chromosome 3 loss versus melanomas with 6p gain [11].
Figure 4. Color fundus photograph of
the  left  eye  in  Case  3  at  initial
presentation  demonstrates  an
inferotemporal choroidal melanoma.
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234Significantly,  the  Vietnamese  choroidal  melanoma  patient
with  chromosome  3  loss  (Case  2)  had  a  gene  expression
profile similar to the larger comparative group of choroidal
melanomas with chromosome 3 loss. The Vietnamese patient
with choroidal melanoma with chromosome 6p gain and the
absence of chromosome 3 loss (Case 1) presented a profile of
gene expression similar to the larger comparative group of
choroidal melanomas with 6p gain.
Overall, clinical presentation of choroidal melanoma in
Vietnamese  patients  closely  paralleled  the  symptoms  and
signs of choroidal melanoma in other ethnic/racial groups and
documented the dense melanin pigmentation characteristic of
choroidal melanoma in Asians of Japanese, Chinese, and Thai
origin [4-6].
Cytogenetic presentation in Vietnamese patients showed
fundamental features of chromosome 3 loss (Case 2) and
chromosome  6p  gain  (Cases  1  and  3)  comparable  to  the
cytogenetic characteristics of primarily Caucasian patients.
Moreover, the gene expression profile of the patient with
chromosome 3 loss (Case 2) and chromosome 6p gain (Case
1) were similar to the gene profiles for the most upregulated
and  most  down-regulated  genes  in  a  primarily  Caucasian
group [11].
Occurrence of biopsy-confirmed melanoma metastasis in
the liver of the Vietnamese patient with chromosome 3 loss
(Case 2) three years after brachytherapy and no evidence of
metastasis in the Vietnamese patients with chromosome 6p
gain  (Cases  1  and  3)  followed  for  an  equal  period  after
brachytherapy was consistent with the high risk of metastasis
associated with chromosome 3 loss.
In Case 2, FISH probing for the centromeric region of
chromosome 3 yielded disomy 3, which was discrepant with
Mapping array data which showed a loss of one copy of
chromosome 3. The reasons for this discrepancy may be that
tumor heterogeneity resulted from different areas of the tumor
biopsied [12-14]. In addition sampling error in the biopsy may
have  resulted  in  an  analysis  of  a  significant  number  of
macrophages or lymphocytes, rather than actual melanoma
cells [15].
Similarities between this small series of three Vietnamese
Asians with choroidal melanoma and the larger experience of
primarily white patients with choroidal melanoma suggests a
similar underlying disease process and infers applicability to
the Vietnamese of prognostic information and, ultimately,
therapeutic measures derived from larger cohorts of white
patients with choroidal melanoma.
Strengths of this report relate to the (1) self-determined
identification of Vietnamese Asians on the basis of ancestry
and  culture,  (2)  characterization  of  clinical  presentation,
diagnosis, treatment and clinical course in Vietnamese men
with choroidal melanoma, and (3) use of identical Mapping
Array  and  Expression  Array  to  characterize  cytogenetic
aberrations and gene expression profiles in Vietnamese men
and a larger cohort of white patients with choroidal melanoma.
Weaknesses include the (1) small series of three Vietnamese
men  with  choroidal  melanoma  and  (2)  rather  short  post-
treatment follow-up of three years.
Although uveal melanoma is rare in Asians, these data
indicate that when it does occur, the underlying chromosome
and  RNA  changes  are  the  same  as  those  that  occur  in
Caucasians. In Vietnamese Asians with heavily pigmented
Figure 5. Expression Array Data Comparison of Two Cases. Normalized GeneChip Human U133 Plus 2.0 expression array data comparing
Case 2 and Case 3 for mRNA expression in the 25 most highly upregulated genes and 20 most down-regulated genes identified in a previous
study of monosomy 3 choroidal melanomas relative to chromosome 6p gain choroidal melanomas [11]. Insufficient RNA was available for
analysis of Case 1.
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235choroidal  melanoma,  clinical  presentation,  cytogenetic
characteristics and gene expression profiles were similar to
larger  series  of  primarily  white  patients  with  choroidal
melanoma. Chromosome 3 loss was associated with a poor
prognosis and development of liver metastasis.
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